$65.55
Manufacturer: Netherlands
Purpose: Inhibits aromatase enzyme to treat hormone receptor-positive breast cancer.
Description
Anastrozol (Anastrozole) Coated Tablets 1 mg. №28
Ingredients
Active ingredient: Anastrozole 1 mg.
Other ingredients: lactose monohydrate, povidone, sodium starch glycolate, magnesium stearate, hypromellose, macrogol 300, titanium dioxide (E171).
Dosage
Adults: The recommended dose is 1 tablet daily, with or without food. Follow your healthcare provider’s instructions for the best results.
Indications
Anastrozol tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.
Contraindications
Do not use Anastrozol tablets if you are allergic to anastrozole or any of the ingredients in the product. Consult your doctor before starting this medication.
Directions
Take Anastrozol tablets exactly as prescribed by your healthcare provider. Do not adjust the dosage without consulting your doctor.
Scientific Evidence
Anastrozole, the active ingredient in Anastrozol tablets, is a selective aromatase inhibitor that has shown efficacy in the treatment of hormone receptor-positive breast cancer. Studies have demonstrated its ability to reduce the risk of cancer recurrence and improve survival rates in postmenopausal women.
Additional Information
It is important to discuss any existing medical conditions and medications with your healthcare provider before starting Anastrozol treatment. Regular monitoring and follow-up appointments are crucial to ensure the medication’s effectiveness and manage any potential side effects.
Pharmacological Effects: Anastrozole works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens to estrogens. By reducing estrogen levels in the body, Anastrozole helps slow or stop the growth of hormone receptor-positive breast cancer cells.
Clinical Trials: Clinical trials have shown that Anastrozole is as effective as or superior to tamoxifen in the adjuvant treatment of early breast cancer. The ATAC (Arimidex, Tamoxifen Alone or in Combination) trial demonstrated improved disease-free survival with Anastrozole compared to tamoxifen.
Recent Reviews